Sort
40,608 grants matching “prostate cancer”
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$675,590Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cloud computing platform for virtual screening and drug discovery.
$675,509Robert J Dockhorn · B-Tech Consulting, Ltd · R44 · FY2015 · GM
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
$675,388Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2020 · CA
Core 2
$675,235Andrea Califano · Columbia University Health Sciences · U54 · FY2010 · CA
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
$675,104Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2025 · CA
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$675,000The Emmes Company, Llc · N01 · FY2012 · EY
THE ROLE OF A NOVEL AR SPLICE VARIANT IN PROSTATE CANCER
$675,000University Of Maryland, Baltimore · · FY2010 · Department of the Army
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$674,794Corinne E. Joshu · Johns Hopkins University · R01 · FY2022 · CA
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer
$674,729Adam S Kibel · Brigham And Women'S Hospital · U01 · FY2024 · CA
3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)
$674,593David L Wilson · Case Western Reserve University · R01 · FY2022 · EB
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial
$674,482Amir Goldkorn · University Of Southern California · R01 · FY2014 · CA
Protein kinase C and lung carcinogenesis
$674,373Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2023 · CA
Clinical Development of Novel Drugs for Children with Refractory Cancers
$674,339Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Helicobacter pylori protein-specific antibodies and colorectal cancer risk
$674,176Meira Epplein · Vanderbilt University · R01 · FY2015 · CA
Fine-mapping of 8q24 and Loci Identified in Genome-Wide Studies for Breast & Colo
$673,902Christopher Alan Haiman · University Of Southern California · R01 · FY2009 · CA
Development of large-field-of-view hyperpolarized MRI
$673,750Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Multi-Modality MRI/CT Markers for Improved Assessment of Prostate Cancer
$673,660Andrew Bright · C4 Imaging, Llc · R44 · FY2015 · CA
Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer
$673,467Christopher A Maher · Washington University · R01 · FY2022 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$673,428Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$673,428Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Core 2
$673,401Andrea Califano · Columbia University Health Sciences · U54 · FY2013 · CA
Role of FH loss in development of HLRCC heriditary kidney cancer
$673,377Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$673,296Corinne E. Joshu · Johns Hopkins University · R01 · FY2023 · CA
Prostate Cancer Diagnosis by Multiparametric Ultrasound
$673,228Ethan J Halpern · Thomas Jefferson University · R01 · FY2020 · CA
Pilot study of an implantable microdevice to test multiple drug responses in prostate cancer patients
$673,221Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2019 · CA